Articles with the keyword: 


Anadis Opens New Approach to Respiratory Disease Control
kavin submitted, created time 2 months 3 weeks (www.medicalnewstoday.com)
Anadis Limited (ASX: ANX), a research-driven biopharmaceutical company focused on polyclonal antibodies to address human disease, announced important progress concerning its accelerated program to develop a nasal antibody spray to provide immediate post-exposure prophylaxis against a range of influenza viruses.
Working with an animal influenza challenge model in the laboratory of Professor Loreena Brown at the Department of Microbiology and Immunology, University of Melbourne, scientists successfully completed a series of proof-in-principal experiments 


Palese submitted, created time 11 months 1 week (pathogens.plosjournals.org)
Using guinea pigs as an animal model we found that influenza viruses are transmitted well at low temperature (5 centigrade) and that no transmission is detected at high temperature (30 centigrade). 


annatto submitted, created time 1 year 5 months (www.virologyj.com)
"According to researchers results demonstrate that both NLS1 and NLS2 on NP can mediate the nuclear uptake of influenza A vRNPs." 


'Virus Sponge' Could Improve Flu Treatments, Diabetes Care, Vaccine Development
penguin submitted, created time 1 year 6 months (www.sciencedaily.com)
Influenza virus H5N1, which caused the recent outbreak of avian flu, may have a new enemy. Researchers at the University of Maryland's A. James Clark School of Engineering have created a "virus sponge" that could filter a patient's blood in a process similar to kidney dialysis, removing the virus from the patient's body. 


Codon conservation in the influenza A virus genome defines RNA packaging signals
athena submitted, created time 1 year 6 months (nar.oxfordjournals.org)
"Genome segmentation facilitates reassortment and rapid evolution of influenza A virus.“ 
\ 1
\